De Cristofaro, E.; Salvatori, S.; Marafini, I.; Zorzi, F.; Alfieri, N.; Musumeci, M.; Calabrese, E.; Monteleone, G.
Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab. J. Clin. Med. 2022, 11, 1679.
https://doi.org/10.3390/jcm11061679
AMA Style
De Cristofaro E, Salvatori S, Marafini I, Zorzi F, Alfieri N, Musumeci M, Calabrese E, Monteleone G.
Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab. Journal of Clinical Medicine. 2022; 11(6):1679.
https://doi.org/10.3390/jcm11061679
Chicago/Turabian Style
De Cristofaro, Elena, Silvia Salvatori, Irene Marafini, Francesca Zorzi, Norma Alfieri, Martina Musumeci, Emma Calabrese, and Giovanni Monteleone.
2022. "Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab" Journal of Clinical Medicine 11, no. 6: 1679.
https://doi.org/10.3390/jcm11061679
APA Style
De Cristofaro, E., Salvatori, S., Marafini, I., Zorzi, F., Alfieri, N., Musumeci, M., Calabrese, E., & Monteleone, G.
(2022). Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab. Journal of Clinical Medicine, 11(6), 1679.
https://doi.org/10.3390/jcm11061679